Results 11 to 20 of about 157,660 (290)

Prevalence and Severity of Hand Eczema in the Dutch General Population: A Cross-sectional, Questionnaire Study within the Lifelines Cohort Study

open access: yesActa Dermato-Venereologica, 2022
Data on chronic hand eczema and severity of hand eczema in the general population is scarce. In this cross-sectional study, a questionnaire was sent to 135,950 Lifelines Cohort Study participants, in order to investigate the prevalence and severity of ...
Angelique N. Voorberg   +2 more
doaj   +1 more source

Siblings, asthma, rhinoconjunctivitis and eczema: a worldwide perspective from the International Study of Asthma and Allergies in Childhood. [PDF]

open access: yes, 2014
BACKGROUND: Associations of larger families with lower prevalences of hay fever, eczema and objective markers of allergic sensitization have been found fairly consistently in affluent countries, but little is known about these relationships in less ...
Aït-Khaled, N   +7 more
core   +2 more sources

Prenatal exposure to TCDD and atopic conditions in the Seveso second generation: a prospective cohort study. [PDF]

open access: yes, 2018
Background2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is a toxic environmental contaminant that can bioaccumulate in humans, cross the placenta, and cause immunological effects in children, including altering their risk of developing allergies. On July 10,
Brambilla, Paolo   +4 more
core   +2 more sources

Factors facilitating shared decision making in eczema: Met and unmet needs from the patient perspectiveCapsule Summary

open access: yesJAAD International, 2023
Background: Research has shown that eczema patients prefer some degree of shared control over treatment decisions, but little is known about factors perceived to be important to facilitate shared decision making (SDM).
Erin Foster, MD, PhD   +3 more
doaj  

IL13genetic polymorphisms, smoking, and eczema in women: a case-control study in Japan [PDF]

open access: yes, 2011
BACKGROUND: Several genetic association studies have examined the relationships between single nucleotide polymorphisms (SNPs) in the IL13 gene and eczema, and have provided contradictory results.
Keiko Tanaka   +2 more
core   +4 more sources

Common mental health disorders in adults with inflammatory skin conditions: nationwide population-based matched cohort studies in the UK

open access: yesBMC Medicine, 2023
Background Psoriasis and atopic eczema are common inflammatory skin diseases. Existing research has identified increased risks of common mental disorders (anxiety, depression) in people with eczema and psoriasis; however, explanations for the ...
Alasdair D. Henderson   +9 more
doaj   +1 more source

Implications of the problem orientated medical record (POMR) for research using electronic GP databases: a comparison of the Doctors Independent Network Database (DIN) and the General Practice Research Database (GPRD). [PDF]

open access: yes, 2003
Background The General Practice Research Database (GPRD) and Doctor's Independent Network Database (DIN), are large electronic primary care databases compiled in the UK during the 1990s.
David P Strachan   +15 more
core   +3 more sources

Factors related to eczema clinical trial participation among adult patients and caregivers

open access: yesContemporary Clinical Trials Communications, 2023
Background: Eczema can be difficult to treat due to its chronic, heterogeneous nature. Effective long-term treatments for adults and children are needed.
Jessica K. Johnson   +3 more
doaj  

Frequent use of paracetamol and risk of allergic disease among women in an Ethiopian population [PDF]

open access: yes, 2011
Introduction The hypothesis that paracetamol might increase the risk of asthma and other allergic diseases have gained support from a range of independent studies.
A Amberbir   +31 more
core   +10 more sources

Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME). [PDF]

open access: yes, 2014
This report provides a summary of the third meeting of the Harmonising Outcome Measures for Eczema (HOME) initiative held in San Diego, CA, U.S.A., 6-7 April 2013 (HOME III).
Admani, S   +43 more
core   +1 more source

Home - About - Disclaimer - Privacy